Trial intelligence / Profile preview

Live attenuated herpes zoster vaccine Phase III trial in Chinese adults

CTR20200167Phase 3Completed

Sponsor
Changchun BCHT Biotechnology Co.
Start
Feb 2020
Modality
Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by Changchun BCHT Biotechnology Co.. Started Feb 2020; status: completed.

02

Drugs

zoster vaccine, live
03

Conditions

herpes zoster (HZ)

Beyond the preview

Go deeper on CTR20200167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20200167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call